Patent Assignment
Reel/Frame 069320/0212
Assignment of Assignor's Interest
Recorded: 2024-11-19
Pages: 8
Assignor
VIEWPOINT THERAPEUTICS, INC.
Executed: 2022-07-21
Assignee
VISUS THERAPEUTICS, INC.
2 NICKERSON STREET SUITE 101, SEATTLE, WASHINGTON, 98109
Covered Property
(1)
Compounds and Formulations for Treating Ophthalmic Diseases
Application:
18/043,146 →
Publication:
US 2023/0322672
Related Assignments
(4)
Other recorded transfers of the patent in this record — the chain of ownership.
Security Interest
Mar 20, 2024
From: VISUS THERAPEUTICS, INC.
To: LSP 6 HOLDING C.V., AS COLLATERAL AGENT
Reel/Frame 066839/0679 →
Release of Security Interest Reel 066839, Frame 0679
Dec 31, 2025
From: LSP 6 HOLDING C.V., AS COLLATERAL AGENT
To: VISUS THERAPEUTICS, INC.
Reel/Frame 074145/0450 →
Security Interest
Jan 9, 2026
From: TENPOINT THERAPEUTICS HOLDING LIMITED; TENPOINT THERAPEUTICS LIMITED; VISUS THERAPEUTICS, INC.; TENPOINT THERAPEUTICS INC.
To: HERCULES CAPITAL, INC., AS AGENT
Reel/Frame 073417/0714 →
Assignment of Assignor's Interest
Jan 29, 2026
From: LOPEZ, MICHAEL S.; DUNYAK, BRYAN M.
To: VIEWPOINT THERAPEUTICS, INC.
Reel/Frame 073623/0554 →